Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


Published ahead of print on January 9, 2008
J Am Soc Nephrol 19: 298-309, 2008
© 2008 American Society of Nephrology
doi: 10.1681/ASN.2007050531
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ASN.2007050531v1
19/2/298    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Terada, Y.
Right arrow Articles by Sasaki, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Terada, Y.
Right arrow Articles by Sasaki, S.

BASIC RESEARCH

Aldosterone-Stimulated SGK1 Activity Mediates Profibrotic Signaling in the Mesangium

Yoshio Terada, Hitoshi Kuwana, Takahiko Kobayashi, Tomokazu Okado, Noriko Suzuki, Takanobu Yoshimoto, Yukio Hirata and Sei Sasaki

Department of Blood Purification and Nephrology, Department of Molecular Endocrinology, Tokyo Medical and Dental University, Tokyo, Japan

Correspondence: Dr. Yoshio Terada, Department of Nephrology and Blood Purification, Tokyo Medical and Dental University, 5-45, Yushima 1-chome, Bunkyo-ku, Tokyo 113-8519, Japan. Phone: 81-3-5803-5662; Fax: 81-3-5803-0225; E-mail: yterada.kid{at}tmd.ac.jp

Received for publication May 2, 2007. Accepted for publication September 6, 2007.

Several recent reports support the hypothesis that aldosterone contributes to the progression of renal injury. Mineralocorticoids increase the expression of serum- and glucocorticoid-inducible protein kinase 1 (SGK1), which is upregulated in several fibrotic diseases. It was hypothesized that SGK1 may mediate the effects of aldosterone on glomerular fibrosis and inflammation. In primary cultures of rat mesangial cells, aldosterone stimulated the expression, phosphorylation, and kinase activity of SGK1, as well as SGK1-dependent NF-{kappa}B activity. Furthermore, aldosterone augmented the promoter activity and protein expression of intercellular adhesion molecule-1 (ICAM-1), which modulates the inflammatory response, and the profibrotic cytokine connective tissue growth factor (CTGF) in an SGK1- and NF-{kappa}B–dependent manner. Similar to the in vitro results, uninephrectomized rats that were treated with aldosterone demonstrated increased glomerular expression of SGK1, ICAM-1, and CTGF proteins than untreated rats; these changes were accompanied by hypertension, glomerulosclerosis, and inflammation. In conclusion, these findings suggest that aldosterone stimulates ICAM-1 and CTGF transcription via the activation of SGK1 and NF-{kappa}B, effects that may contribute to the progression of aldosterone-induced mesangial fibrosis and inflammation.




This article has been cited by other articles:


Home page
 J. Am. Soc. Nephrol.Home page
N. J. Brown
Salt in the Wound
J. Am. Soc. Nephrol., January 1, 2009; 20(1): 5 - 6.
[Full Text] [PDF]


HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP

Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673